Literature DB >> 27917818

Galectin-3: A biochemical marker to detect paroxysmal atrial fibrillation?

Yusuf Selcoki1, H İbrahim Aydin, Tugrul H Celik, Ahmet Isleyen, Ali Erayman, M Bora Demircelik, Hilmi Demirin, Aydin Kosus, Beyhan Eryonucu.   

Abstract

PURPOSE: Atrial fibrillation (AF) is the most common form of arrhythmia. AF leads to electrical remodelling and fibrosis of the atria; however, the mechanism(s) remain poorly understood. Galectin-3 is a potential mediator of cardiac fibrosis. The present study aimed to examine the relationship between serum galectin-3 levels and paroxysmal AF.
METHODS: Forty-six patients with paroxysmal AF and preserved left ventricular systolic function, and 38 age- and gender-matched control subjects, were involved in the study. Serum galectin-3 levels were analyzed with an enzyme-linked immunosorbent assay (ELISA).
RESULTS: Serum galectin-3 levels (median 1.38 ng/mL; 1.21 ng/mL-1.87 ng/mL; p< 0.001) were significantly elevated in patients with paroxysmal AF compared with the control. Left atrial diameter was significantly higher in patients with paroxysmal AF (41.2±3.0 mm vs. 39.6±3.3 mm). Left atrial diameter was found to be significantly correlated with serum galectin-3 levels in patients with paroxysmal AF (r= 0.378, p= 0.001).
CONCLUSION: Serum galectin-3 levels are significantly elevated and significantly correlated with left atrial diameter in patients with paroxysmal AF.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27917818

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  4 in total

1.  Galectin-3 in Acute Myocardial Infarction Patients with Atrial Fibrillation.

Authors:  Dragana Stanojevic; Svetlana Apostolovic; Dragana Stokanovic; Stefan Momčilović; Tatjana Jevtovic-Stoimenov; Sonja Salinger-Martinovic; Tomislav Kostic; Valentina N Nikolic
Journal:  Med Princ Pract       Date:  2019-02-06       Impact factor: 1.927

2.  Increased serum lysyl oxidase-like 2 levels correlate with the degree of left atrial fibrosis in patients with atrial fibrillation.

Authors:  Yingming Zhao; Kangting Tang; Xu Tianbao; Junhong Wang; Jin Yang; Dianfu Li
Journal:  Biosci Rep       Date:  2017-11-21       Impact factor: 3.840

3.  Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis.

Authors:  Mengqi Gong; Angel Cheung; Qun-Shan Wang; Guangping Li; Christos A Goudis; George Bazoukis; Gregory Y H Lip; Adrian Baranchuk; Panagiotis Korantzopoulos; Konstantinos P Letsas; Gary Tse; Tong Liu
Journal:  J Clin Lab Anal       Date:  2020-01-09       Impact factor: 2.352

4.  Predictors of Total Mortality and Serious Arrhythmic Events in Non-Ischemic Heart Failure Patients: The Role of Galectin-3.

Authors:  Adriano Nunes Kochi; Mauricio Pimentel; Michael Andrades; Tiago Zimerman; Leandro Ioschpe Zimerman; Luis Eduardo Rohde
Journal:  Arq Bras Cardiol       Date:  2021-09       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.